Biosimilars – a risky bet?
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 3 (Table of Contents)
Published: 20 Mar-2009
DOI: 10.3833/pdr.v2009.i3.1080 ISSN: 1756-7874
Section: Editorial
Fulltext:
Abstract
The market for biosimilars will increase as more biologic drugs reach patent expiry within the next 10 years...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS